In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Tandem Diabetes Care's current price of $15.77 sits below its $17.82 fair value, indicating potential undervaluation with a 13% implied upside and no downside risk scenarios. Valuations vary widely, from deeply negative DCF outcomes to high analyst targets, reflecting conflicting growth and profitability prospects. Poor financial health scores highlight significant risk despite strong liquidity.